Form 8-K - Current report:
SEC Accession No. 0001214659-25-003727
Filing Date
2025-03-03
Accepted
2025-03-03 16:30:44
Documents
31
Period of Report
2025-03-03
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 p312508k.htm   iXBRL 8-K 29033
2 EXHIBIT 3.1 ex3_1.htm EX-3.1 4331
3 EXHIBIT 3.2 ex3_2.htm EX-3.2 11386
7 GRAPHIC ex32-001.jpg GRAPHIC 96432
8 GRAPHIC ex32-002.jpg GRAPHIC 333919
9 GRAPHIC ex32-003.jpg GRAPHIC 349908
10 GRAPHIC ex32-004.jpg GRAPHIC 302466
11 GRAPHIC ex32-005.jpg GRAPHIC 423368
12 GRAPHIC ex32-006.jpg GRAPHIC 450887
13 GRAPHIC ex32-007.jpg GRAPHIC 447377
14 GRAPHIC ex32-008.jpg GRAPHIC 423938
15 GRAPHIC ex32-009.jpg GRAPHIC 459838
16 GRAPHIC ex32-010.jpg GRAPHIC 477257
17 GRAPHIC ex32-011.jpg GRAPHIC 439411
18 GRAPHIC ex32-012.jpg GRAPHIC 396451
19 GRAPHIC ex32-013.jpg GRAPHIC 391986
20 GRAPHIC ex32-014.jpg GRAPHIC 318073
21 GRAPHIC ex32-015.jpg GRAPHIC 38779
22 GRAPHIC ex32-016.jpg GRAPHIC 186902
  Complete submission text file 0001214659-25-003727.txt   7854851

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE alzn-20250303.xsd EX-101.SCH 2991
5 XBRL LABEL FILE alzn-20250303_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE alzn-20250303_pre.xml EX-101.PRE 22343
33 EXTRACTED XBRL INSTANCE DOCUMENT p312508k_htm.xml XML 4031
Mailing Address 3500 LENOX RD. NE SUITE 1500 ATLANTA GA 30326
Business Address 3500 LENOX RD. NE SUITE 1500 ATLANTA GA 30326 844-722-6333
Alzamend Neuro, Inc. (Filer) CIK: 0001677077 (see all company filings)

EIN.: 811822909 | State of Incorp.: DE | Fiscal Year End: 0430
Type: 8-K | Act: 34 | File No.: 001-40483 | Film No.: 25698492
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)